I

n just a few years, CRISPR, the revolutionary gene editing technology, has become science’s “it” discipline, giving birth to a bitter patent dispute, billions in biotech investments, and an in-development primetime TV drama. But unlike the comparatively less buzzy pursuits of virology and animal husbandry, CRISPR has lacked one of academia’s unsexier badges of honor: a peer-reviewed journal to call its own.

That’s going to change come 2018 with the arrival of The CRISPR Journal, a bimonthly publication that seeks to chronicle every breakthrough, ethical debate, and legal quandary in the world of gene editing.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X